LFCR Annual Accounts Receivable
$31.15 M
+$2.13 M+7.34%
26 May 2024
Summary:
As of January 23, 2025, LFCR annual accounts receivable is $31.15 million, with the most recent change of +$2.13 million (+7.34%) on May 26, 2024. During the last 3 years, it has fallen by -$10.28 million (-24.81%). LFCR annual accounts receivable is now -59.12% below its all-time high of $76.21 million, reached on May 1, 2020.LFCR Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LFCR Quarterly Accounts Receivable
$25.17 M
+$21.00 K+0.08%
24 November 2024
Summary:
As of January 23, 2025, LFCR quarterly accounts receivable is $25.17 million, with the most recent change of +$21.00 thousand (+0.08%) on November 24, 2024. Over the past year, it has dropped by -$6.28 million (-19.97%). LFCR quarterly accounts receivable is now -66.98% below its all-time high of $76.21 million, reached on May 1, 2020.LFCR Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LFCR Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.3% | -20.0% |
| 3 y3 years | -24.8% | -20.0% |
| 5 y5 years | -55.2% | -64.0% |
LFCR Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -24.8% | +7.3% | -61.5% | +0.1% |
| 5 y | 5-year | -59.1% | +7.3% | -67.0% | +0.1% |
| alltime | all time | -59.1% | +120.0% | -67.0% | +148.5% |
Lifecore Biomedical Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Nov 2024 | - | $25.17 M(+0.1%) |
| Aug 2024 | - | $25.14 M(-19.3%) |
| May 2024 | $31.15 M(+7.3%) | $31.15 M(-0.9%) |
| Feb 2024 | - | $31.45 M(+4.1%) |
| Nov 2023 | - | $30.20 M(+13.5%) |
| Aug 2023 | - | $26.62 M(-8.3%) |
| May 2023 | $29.02 M(-24.2%) | $29.02 M(-10.3%) |
| Feb 2023 | - | $32.37 M(-9.3%) |
| Nov 2022 | - | $35.69 M(-12.8%) |
| Aug 2022 | - | $40.93 M(+6.8%) |
| May 2022 | $38.31 M(-7.5%) | $38.31 M(-22.7%) |
| Feb 2022 | - | $49.56 M(-24.1%) |
| Nov 2021 | - | $65.28 M(+5.4%) |
| Aug 2021 | - | $61.96 M(+49.5%) |
| May 2021 | $41.43 M(-45.6%) | - |
| May 2021 | - | $41.43 M(-40.5%) |
| Feb 2021 | - | $69.58 M(+4.6%) |
| Nov 2020 | - | $66.55 M(+2.3%) |
| Aug 2020 | - | $65.03 M(-14.7%) |
| May 2020 | $76.21 M(+9.5%) | $76.21 M(+9.2%) |
| Feb 2020 | - | $69.76 M(-0.3%) |
| Nov 2019 | - | $69.96 M(+13.9%) |
| Aug 2019 | - | $61.40 M(-11.7%) |
| May 2019 | $69.56 M(+29.1%) | $69.56 M(+15.2%) |
| Feb 2019 | - | $60.39 M(+13.0%) |
| Nov 2018 | - | $53.42 M(+9.8%) |
| Aug 2018 | - | $48.66 M(-9.7%) |
| May 2018 | $53.88 M(+17.4%) | $53.88 M(+6.8%) |
| Feb 2018 | - | $50.44 M(-10.5%) |
| Nov 2017 | - | $56.36 M(+17.8%) |
| Aug 2017 | - | $47.85 M(+4.3%) |
| May 2017 | $45.90 M(-1.1%) | $45.90 M(-0.0%) |
| Feb 2017 | - | $45.92 M(-8.2%) |
| Nov 2016 | - | $50.01 M(+13.3%) |
| Aug 2016 | - | $44.15 M(-4.9%) |
| May 2016 | $46.41 M(-0.2%) | $46.41 M(+8.1%) |
| Feb 2016 | - | $42.92 M(-14.6%) |
| Nov 2015 | - | $50.28 M(+12.9%) |
| Aug 2015 | - | $44.52 M(-4.2%) |
| May 2015 | $46.48 M(+3.9%) | $46.48 M(+2.6%) |
| Feb 2015 | - | $45.31 M(-13.4%) |
| Nov 2014 | - | $52.30 M(+19.4%) |
| Aug 2014 | - | $43.80 M(-2.1%) |
| May 2014 | $44.73 M(+21.7%) | $44.73 M(+8.5%) |
| Feb 2014 | - | $41.23 M(-1.5%) |
| Nov 2013 | - | $41.88 M(+26.2%) |
| Aug 2013 | - | $33.18 M(-9.7%) |
| May 2013 | $36.74 M | $36.74 M(-2.2%) |
| Feb 2013 | - | $37.58 M(-8.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Nov 2012 | - | $40.91 M(+33.8%) |
| Aug 2012 | - | $30.56 M(-5.3%) |
| May 2012 | $32.27 M(+46.0%) | $32.27 M(+35.9%) |
| Feb 2012 | - | $23.74 M(-19.2%) |
| Nov 2011 | - | $29.37 M(+41.4%) |
| Aug 2011 | - | $20.77 M(-6.1%) |
| May 2011 | $22.11 M(+14.1%) | $22.11 M(+13.5%) |
| Feb 2011 | - | $19.48 M(-22.5%) |
| Nov 2010 | - | $25.13 M(+24.1%) |
| Aug 2010 | - | $20.25 M(+4.6%) |
| May 2010 | $19.37 M(+21.8%) | $19.37 M(+32.1%) |
| Feb 2010 | - | $14.66 M(-14.0%) |
| Nov 2009 | - | $17.05 M(-13.6%) |
| Aug 2009 | - | $19.73 M(+24.1%) |
| May 2009 | $15.90 M(-20.0%) | $15.90 M(+23.9%) |
| Feb 2009 | - | $12.84 M(-20.5%) |
| Nov 2008 | - | $16.14 M(-15.3%) |
| Aug 2008 | - | $19.06 M(-4.1%) |
| May 2008 | $19.87 M(+9.3%) | $19.87 M(+30.1%) |
| Feb 2008 | - | $15.28 M(-15.4%) |
| Nov 2007 | - | $18.07 M(-1.1%) |
| Aug 2007 | - | $18.26 M(+0.4%) |
| May 2007 | $18.18 M(+14.7%) | $18.18 M(+7.3%) |
| Feb 2007 | - | $16.95 M(+1.3%) |
| Nov 2006 | - | $16.72 M(+6.0%) |
| Aug 2006 | - | $15.78 M(-0.4%) |
| May 2006 | $15.85 M(-0.2%) | $15.85 M(+19.6%) |
| Feb 2006 | - | $13.25 M(-29.5%) |
| Nov 2005 | - | $18.79 M(+5.8%) |
| Aug 2005 | - | $17.76 M(+11.8%) |
| May 2005 | $15.88 M(+3.5%) | $15.88 M(+36.2%) |
| Feb 2005 | - | $11.66 M(-26.0%) |
| Nov 2004 | - | $15.74 M(+0.6%) |
| Aug 2004 | - | $15.65 M(+1.9%) |
| May 2004 | $15.35 M(-11.3%) | $15.35 M(+35.4%) |
| Feb 2004 | - | $11.34 M(-13.6%) |
| Nov 2003 | - | $13.12 M(+29.6%) |
| Aug 2003 | - | $10.13 M(-37.6%) |
| May 2003 | $17.31 M(-9.1%) | - |
| Apr 2003 | - | $16.22 M(+10.2%) |
| Jan 2003 | - | $14.72 M(-22.7%) |
| Oct 2002 | $19.04 M(+34.5%) | $19.04 M(-11.6%) |
| July 2002 | - | $21.54 M(+28.6%) |
| Apr 2002 | - | $16.75 M(+0.7%) |
| Jan 2002 | - | $16.63 M(+17.5%) |
| Oct 2001 | $14.16 M(-33.4%) | $14.16 M(-26.5%) |
| July 2001 | - | $19.26 M(-1.1%) |
| Apr 2001 | - | $19.47 M(+5.1%) |
| Jan 2001 | - | $18.53 M(-12.9%) |
| Oct 2000 | $21.27 M | $21.27 M |
FAQ
- What is Lifecore Biomedical annual accounts receivable?
- What is the all time high annual accounts receivable for Lifecore Biomedical?
- What is Lifecore Biomedical annual accounts receivable year-on-year change?
- What is Lifecore Biomedical quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Lifecore Biomedical?
- What is Lifecore Biomedical quarterly accounts receivable year-on-year change?
What is Lifecore Biomedical annual accounts receivable?
The current annual accounts receivable of LFCR is $31.15 M
What is the all time high annual accounts receivable for Lifecore Biomedical?
Lifecore Biomedical all-time high annual accounts receivable is $76.21 M
What is Lifecore Biomedical annual accounts receivable year-on-year change?
Over the past year, LFCR annual accounts receivable has changed by +$2.13 M (+7.34%)
What is Lifecore Biomedical quarterly accounts receivable?
The current quarterly accounts receivable of LFCR is $25.17 M
What is the all time high quarterly accounts receivable for Lifecore Biomedical?
Lifecore Biomedical all-time high quarterly accounts receivable is $76.21 M
What is Lifecore Biomedical quarterly accounts receivable year-on-year change?
Over the past year, LFCR quarterly accounts receivable has changed by -$6.28 M (-19.97%)